Manufacturer record
Vertex Pharma Chemicals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Vertex Pharma Chemicals (Puducherry) were declared Not of Standard Quality between December 2024 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: VSPT2545, Amitriptyline Tablets IP 25mg (exp Aug 2027). DTL, Bengaluru, Karnataka (state lab) found it not of standard quality: Description. Listed in the March 2026 alert.
Records by type
5 records linked to Vertex Pharma Chemicals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amitriptyline Tablets IP 25mg | Batch VSPT2545Mfg Sep 2025 · Exp Aug 2027 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Mar 2026 |
| Levocetirizine Hydrochloride & Montelukast Sodium Suspension(LEMONT KID) | Batch VS2538Mfg Oct 2025 · Exp Sep 2027 | Failed Description and assay (For Levocetirizine hydrochloride) & Incorrect LabellingAssay | DTL, PuducherryState lab | Dec 2025 |
| (Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin Syrup) | Batch VS2523Mfg Jul 2025 · Exp Jun 2027 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| Moxivin-CV 625 (Amoxycillin and Potassium Calvulnate Tablets IP) | Batch VMIT2404Mfg Oct 2024 · Exp Sep 2026 | The Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to Identification of Potassium Clavulanate, Uniformity of weight and content of Amoxycillin in Amoxycillin Trihydrate and Clavulanic Acid in Potassium Clavulanate (Deemed to be spurious).Identification | DTL MaduraiState lab | Apr 2025 |
| O Mak-200 | Batch VMWT240 7Mfg Jun 2024 · Exp Mar 2026 | Sample does not conform to IP Specification of Ofloxacin Tablets with respect to the content of Ofloxacin.Other | DTL MaduraiState lab | Dec 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.